NCL is not a well-studied autoantigen, but its autoantigenicity was shown on a 25-autoantigen array study in which NCL was the 4th most prominent SLE patient autoantigen following dsDNA, ssDNA, and Ro-52/SSA (22). This evidence concerns the gene TRIM21 and systemic lupus erythematosus.